WCN'25 HIT! High Impact Clinical Trials – What and Why

Only available as part of a package

WCN'25 HIT! High Impact Clinical Trials – What and Why

Key:

Complete
Failed
Available
Locked
Combination Effect of Finerenone and Empagliflozin in Participants With Chronic Kidney Disease and Type 2 Diabetes Using a UACR Endpoint Study (CONFIDENCE)
Open to view video.
Open to view video.
You must register to access.
Clinical and Safety Outcomes of Semaglutide by CKD Severity in the FLOW trial
Open to view video.
Open to view video.
You must register to access.
Results From the REGENCY Trial Assessing Efficacy and Safety of Obinutuzumab in Active Lupus Nephritis
Open to view video.
Open to view video.
You must register to access.